Vistagen Therapeutics, Inc. (VTGN)
Nasdaq: VTGN · CIK 0001411685 · United States
Every official Vistagen Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open VTGN filings
Vistagen Therapeutics, Inc. documents
- Vistagen Therapeutics, Inc. 10-K 2026VTGN 10-K 2026: annual report for fiscal 2026
- Vistagen Therapeutics, Inc. 10-K 2025VTGN 10-K 2025: annual report for fiscal 2025
- Vistagen Therapeutics, Inc. 10-K 2024VTGN 10-K 2024: annual report for fiscal 2024
- Vistagen Therapeutics, Inc. 10-K 2023VTGN 10-K 2023: annual report for fiscal 2023
- Vistagen Therapeutics, Inc. 10-K 2022VTGN 10-K 2022: annual report for fiscal 2022
- Vistagen Therapeutics, Inc. 10-Q 2026VTGN 10-Q 2026: quarterly report for fiscal 2026
- Vistagen Therapeutics, Inc. 10-Q 2025VTGN 10-Q 2025: quarterly report for fiscal 2025
- Vistagen Therapeutics, Inc. 10-Q 2024VTGN 10-Q 2024: quarterly report for fiscal 2024
- Vistagen Therapeutics, Inc. 10-Q 2023VTGN 10-Q 2023: quarterly report for fiscal 2023
- Vistagen Therapeutics, Inc. 10-Q 2022VTGN 10-Q 2022: quarterly report for fiscal 2022
- Vistagen Therapeutics, Inc. 8-K 2026VTGN 8-K 2026: current report for fiscal 2026
- Vistagen Therapeutics, Inc. 8-K 2025VTGN 8-K 2025: current report for fiscal 2025
- Vistagen Therapeutics, Inc. 8-K 2024VTGN 8-K 2024: current report for fiscal 2024
- Vistagen Therapeutics, Inc. 8-K 2023VTGN 8-K 2023: current report for fiscal 2023
- Vistagen Therapeutics, Inc. 8-K 2022VTGN 8-K 2022: current report for fiscal 2022
- Vistagen Therapeutics, Inc. DEF 14A 2026VTGN DEF 14A 2026: proxy statement for fiscal 2026
- Vistagen Therapeutics, Inc. DEF 14A 2025VTGN DEF 14A 2025: proxy statement for fiscal 2025
- Vistagen Therapeutics, Inc. DEF 14A 2024VTGN DEF 14A 2024: proxy statement for fiscal 2024
- Vistagen Therapeutics, Inc. DEF 14A 2023VTGN DEF 14A 2023: proxy statement for fiscal 2023
- Vistagen Therapeutics, Inc. DEF 14A 2022VTGN DEF 14A 2022: proxy statement for fiscal 2022
- Vistagen Therapeutics, Inc. Form 4 2026VTGN Form 4 2026: insider trading filing for fiscal 2026
- Vistagen Therapeutics, Inc. Form 4 2025VTGN Form 4 2025: insider trading filing for fiscal 2025
- Vistagen Therapeutics, Inc. Form 4 2024VTGN Form 4 2024: insider trading filing for fiscal 2024
- Vistagen Therapeutics, Inc. Form 4 2023VTGN Form 4 2023: insider trading filing for fiscal 2023
- Vistagen Therapeutics, Inc. Form 4 2022VTGN Form 4 2022: insider trading filing for fiscal 2022
- Vistagen Therapeutics, Inc. S-1 2026VTGN S-1 2026: registration statement for fiscal 2026
- Vistagen Therapeutics, Inc. S-1 2025VTGN S-1 2025: registration statement for fiscal 2025
- Vistagen Therapeutics, Inc. S-1 2024VTGN S-1 2024: registration statement for fiscal 2024
- Vistagen Therapeutics, Inc. S-1 2023VTGN S-1 2023: registration statement for fiscal 2023
- Vistagen Therapeutics, Inc. S-1 2022VTGN S-1 2022: registration statement for fiscal 2022
- Vistagen Therapeutics, Inc. 13F 2026VTGN 13F 2026: institutional holdings for fiscal 2026
- Vistagen Therapeutics, Inc. 13F 2025VTGN 13F 2025: institutional holdings for fiscal 2025
- Vistagen Therapeutics, Inc. 13F 2024VTGN 13F 2024: institutional holdings for fiscal 2024
- Vistagen Therapeutics, Inc. 13F 2023VTGN 13F 2023: institutional holdings for fiscal 2023
- Vistagen Therapeutics, Inc. 13F 2022VTGN 13F 2022: institutional holdings for fiscal 2022
More companies